|  | Spine (ACDF/ACDA) | Foot&Ankle (HalluxValgus/Rigidus) | Hip (THA) | Knee (Knee Scope) | Shoulder (TSA/RTSA) | Hand (1st CMCarthroplasty) |
---|---|---|---|---|---|---|---|
PreOp | Gabapentin (PO) | 300 mg (or doublecurrent up to 900) | 300 mg | 300 mg | 300 mg | 300 mg | 300 mg |
Tylenol (IV) | 1000 mg (maysubstitute to PO ifIV Tylenol is notavailable) | 1000 mg (maysubstitute to PO if IVTylenol is notavailable) | 1000 mg (maysubstitute toPO if IV Tylenolis not available) | 1000 mg (maysubstitute to PO if IVTylenol is not available) | 1000 mg (maysubstitute to PO if IVTylenol is not available) | 1000 mg (maysubstitute to POif IV Tylenol isnot available) | |
Meloxicam (PO) | 15 mg | 15 mg | 15 mg | 15 mg | 15 mg | 15 mg | |
Scopalamine Patch | Yes (if age < 75) | Yes (if age < 75) | Yes (if age < 75) | Yes (if age < 75) | Yes (if age < 75) | Yes (if age < 75) | |
Single-shot Spinal |  |  | 1.5-2.0 cc 0.75%Bupivacaine(upright in OR) |  |  |  | |
IntraOp | Local Injection | 0.5% Marcaineplain 5 cc | None | CERT | 0.25% Marcaine plain20-30 mL (based onbody habitus) | Exparel 20 cc(suspended in 20 cc0.25% Marcaine) orCERT | None |
Block | Â | Regional Ankle Block | Â | Â | Brachial Plexus Block | Brachial PlexusBlock | |
Toradol | 30 mg IV push ×1 dose (adjust forCrCl) - (given atend of sx or inPACU) | 30 mg IV push × 1dose (adjust for CrCl)- (given at end of sxor in PACU) | 30 mg IV push × 1 dose (adjustfor CrCl) - (givenat end of sx orin PACU) | 30 mg IV push × 1 dose (adjust for CrCl)- (given at end of sx orin PACU) | 30 mg IV push ×  1dose (adjust for CrCl) -(given at end of sx orin PACU) | 30 mg IV push × 1 dose (adjustfor CrCl) - (givenat end of sx orin PACU) | |
Zofran (IV) | 4 mg | 4 mg | 4 mg | 4 mg | 4 mg | 4 mg | |
Decadron | 10 mg | 10 mg | 10 mg | 10 mg | 10 mg | 10 mg | |
PACU | Cryotherapy | Â | Yes | Yes | Yes | Yes (q8h) | Yes |
Tylenol (IV) - *up todaily maximumdose allowable perinstitution | 1000 mg q6h PRN* | 1000 mg q6h PRN* | 1000 mg q6hr ×4doses (continuesinto postop) (maysubstitute to PO ifIV Tylenol is notavailable) | 1000 mg q6h PRN* | 1000 mg q6h PRN* | 1000 mg q6h PRN* | |
Tylenol (PO) - *upto daily maximumdose allowable perinstitution | 500 mg q6h PRN* | 500 mg q6h PRN* |  | 500 mg q6h PRN* | 500 mg q6h PRN* | 500 mg q6h PRN* | |
PostOp | Cryotherapy | Â | optional | Yes (q8h) | optional | Yes (q8h) | optional |
Toradol (IV) | 15 mg q8h ×4doses (can beredosed to atotal of 30 mg q8h) |  | 15 mg q8h ×5doses (can beredosed to a totalof 30 mg q8h) -available for rescue |  | 15 mg q8h ×4 doses(can be redosed to atotal of 30 mg q8h) |  | |
Tylenol (IV) - *up todaily maximumdose allowableper institution | 1000 mg q6h PRN* |  | 1000 mg q6h PRN* |  | 1000 mg q6hr PRN* |  | |
Tylenol (PO) - *upto daily maximumdose allowable perinstitution | 500 mg q6h PRN* |  | 500 mg q6hr PRN* |  | 500 mg q6hr PRN* |  | |
Gabapentin | 300 mg PO(or double currentup to 900) |  | 300 mg q8h |  | 300 mg q8h |  | |
Meloxicam |  |  | 7.5 mg q24h |  |  |  | |
Decadron |  |  | 10 mg (1 dose -postop day #1) |  |  |  | |
Discharge | Cryotherapy | Â | Yes | Â | Yes | Yes | Yes |
Toradol (PO) |  | 10 mg TID x 5d |  | 10 mg TID x 5d |  | 10 mg TID x 5d | |
Meloxicam | 15 mg Q24hr × 14d | (After 5 days ofToradol) 15 mg q24hrx 28d | 15 mg q24h x 28d | (After 5 days ofToradol) 15 mgq24hr x 28d | 15 mg q24hr x 28d | (After 5 days ofToradol) 15 mgq24hr x 28d | |
Gabapentin | 300 mg PO(or double currentup to 900) ×14 day(initiate wean onpatients with preopuse) | 300 mg q8h × 14d | 300 mg q8h × 14d | 300 mg q8h ×  14d | 300 mg q8h ×  14d | 300 mg q8h ×  14d | |
Tylenol | 500 mg q4h PRN | 500 mg q4h PRN | 325 mg q4h PRN | 500 mg q4h PRN | 500 mg q4h PRN | 500 mg q4h PRN | |
ASA |  |  | 81 mg BID x 28d |  | 81 mg BID x 28d |  |